Overview
Yun-ching Chang practices in Kaohsiung, Taiwan. Chang is rated as an Advanced expert by MediFind in the treatment of Muscle Atrophy. Their top areas of expertise are Muscle Atrophy, Rhabdomyosarcoma, Doxorubicin-Induced Cardiomyopathy, and Oral Squamous Cell Carcinoma.
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of Muscle Atrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle AtrophyChang isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Cardiomyopathy Due to Anthracyclines
- Diabetic NephropathyChang isExperienced. Learn about Diabetic Nephropathy.
- Doxorubicin-Induced Cardiomyopathy
- Nasopharyngeal CarcinomaChang isExperienced. Learn about Nasopharyngeal Carcinoma.
- Oral Squamous Cell CarcinomaChang isExperienced. Learn about Oral Squamous Cell Carcinoma.
- RhabdomyosarcomaChang isExperienced. Learn about Rhabdomyosarcoma.